Uniprix banner extends its reach
Uniprix Group is heading into 2013 with a reinforced brand and a bigger presence in its Quebec market area.
Uniprix Group is heading into 2013 with a reinforced brand and a bigger presence in its Quebec market area.
By the close of 2012 two key questions regarding the Affordable Care Act were finally addressed: one, whether the health care reform law is constitutional and, two, whether it would be repealed under a new administration.
Home care provider ResCare Inc. plans to offer Walgreen Co.’s DailyMed prescription service.
Chain drug executives are sounding an upbeat tone as they size up their prospects for 2013. Though most executives express concern about fiscal developments in Washington, they are confident in the outlook for the retail pharmacy industry.
Thrifty White Pharmacy is reinventing the essential component of chain drug retailing by recasting pharmacists as patient counselors and practitioners of medication therapy management.
For his leadership in marshalling his team and executing a well-thought-out pharmacy plan, Rite Aid Corp. executive vice president of pharmacy Robert Thompson has been named Pharmacy Executive of the Year by Chain Drug Review. Pharmacists at Rite Aid are making a bigger commitment to health care.
No more confusing or misunderstood retail or health care alliance exists today than the relationship among the CVS drug chain, the Caremark PBM and the MinuteClinic immediate-care network.
Chattem Inc., the U.S. consumer health division of Sanofi, has completed the acquisition of the worldwide rights to the Rolaids antacid brand from the McNeil Consumer Healthcare Division of McNeil-PPC Inc.
Just as no two patients are alike, no single strategy should serve as the approach to improving medication adherence. That’s one of the principles behind the Patient Empowerment Program (PEP) that can be used by pharmacists to help improve compliance.
PharmaChoice, one of Canada’s largest pharmacy networks, is slated to pilot the PreVu skin cholesterol test from Miraculins Inc. in Ontario and Atlantic Canada.
When the editors of Chain Drug Review looked back at 2012 with an eye toward identifying the executives who had the biggest impact on the industry, one event and the people behind it clearly stood out: the unprecedented partnership Walgreen Co.
Pharmacists at Rite Aid Corp. are making a bigger commitment to health care. Embracing a broader role, the drug chain’s pharmacy team is on a mission to not just provide vital medications but also help the people and the communities they serve improve their overall health and wellness.
Thrifty White Pharmacy is reinventing the essential component of chain drug retailing by recasting pharmacists as patient counselors and practitioners of medication therapy management.
Chain drug executives are sounding an upbeat tone as they size up their prospects for 2013. Though most executives express concern about fiscal developments in Washington, they are confident in the outlook for the retail pharmacy industry.
Rite Aid Corp. reported its first quarterly profit since May 2007, thanks largely to generic drug sales that bolstered gross margin as well as improved front-end sales. The bottom line for the 13-week fiscal 2013 third quarter ended December 1 swung to a net profit of $61.9 million, or 7 cents
Denise Carpenter has been named president and chief executive officer of the Canadian Association of Chain Drug Stores. Before joining CACDS, she served as president and CEO of the Canadian Nuclear Association (CNA) from 2009 to 2012.